Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus

Virology

Volumn 272, Issue 2, 2000, Pages 347-356

  Donahoe, Sean M ^a   Moretto, Walter J ^a   Samuel, Rachel V ^b   Metzner, Karin J ^d   Marx, Preston A ^c   Hanke, Tomas ^b   Connor, Ruth I ^a   Nixon, Douglas F ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c TULANE UNIVERSITY MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; EPITOPE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS PATHOGENESIS;

EID: 0034608831     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0404     Document Type: Article

References (43)

1. Akridge R., Hladik F., Markee J., Alef C., Kelley H., Collier A., McElrath M. J. Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure. Immunol. Lett. 66:1999;15-19.
2. Allen T. M., Sidney J., del Guercio M. F., Glickman R. L., Lensmeyer G. L., Wiebe D. A., DeMars R., Pauza C. D., Johnson R. P., Sette A., Watkins D. I. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160:1998;6062-6071.
3. Allen, T, and, Watkins, D. 1998, SIV and SHIV CTL epitopes identified in macaques, http://hiv-web.lanl.gov/immunology/ , IV8-IV13.
4. Altman J. D., Moss P. A. H., Golder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
5. Bernard N., Yannakis C., Lee J., Tsoukas C. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J. Infect. Dis. 179:1999;538-547.
6. Butz E. A., Bevan M. J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity. 8:1998;167-175.
7. Cheynier R., Langlade D. P., Marescot M. R., Blanche S., Blondin G., Wain H. S., Griscelli C., Vilmer E., Plata F. Cytotoxic T lymphocyte responses in the preipheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:1992;2211-2217.
8. Connor R., Montefiori D., Binley J., Moore J., Bonhoeffer S., Gettie A., Fenamore E., Sheridan K., Ho D., Dailey P., Marx P. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72:1998;7501-7509.
9. De Maria A., Cirillo C., Moretta L. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J. Infect. Dis. 170:1994;1296-1299.
10. Doherty P. C. The numbers game for virus-specific CD8+ T cells. Science. 280:1998;227.
11. Dyer W. B., Ogg G. S., Demoitie M. A., Jin X., Geczy A. F., Rowland-Jones S. L., McMichael A. J., Nixon D. F., Sullivan J. S. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J. Virol. 73:1999;436-443.
12. Evans D. T., Piekarczyk M. S., Allen T. M., Boyson J. E., Yeager M., Hughes A. L., Gotch F. M., Hinshaw V. S., Watkins D. I. Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism. J. Immunol. 159:1997;1374-1382.
13. Fowke K. R., Nagelkerke N. J., Kimani J., Simonsen J. N., Anzala A. O., Bwayo J. J., MacDonald K. S., Ngugi E. N., Plummer F. A. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya [see comments]. Lancet. 348:1996;1347-1351.
14. Hanke T., Neumann V. C., Blanchard T. J., Sweeney P., Hill A. V., Smith G. L., McMichael A. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime. Vaccine. 17:1999;589-596.
15. Johnson R., Glickman R., Yang J., Kaur A., Dion J., Mulligan M., Desrosiers R. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J.Virol. 71:1997;7711-7718.
16. Jordan H. L., Kuroda M. J., Schmitz J. E., Steenbeke T., Forman M. A., Letvin N. L. Detection of simian immunodeficiency virus Gag-specific CD8(+) T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Virol. 73:1999;4508-4512.
17. Kakimoto W. M., Gettie A., Smith S., Donahoe S. M., Jin X., Marx P., Connor R., Nixon D. F. Comparison of restimulation methods to elicit SIV specific cytotoxic T-lymphocytes (CTL) in vitro: Staphylococcal enterotoxin B (SEB) provides a novel method for the quantification of SIV specific CTL precursors. Immunol. Lett. 66:1999;135-140.
18. Kern F., Surel I. P., Brock C., Freistedt B., Radtke H., Scheffold A., Blasczyk R., Reinke P., Schneider-Mergener J., Radbruch A., Walden P., Volk H. D. T-cell epitope mapping by flow cytometry. Nat. Med. 4:1998;975-978.
19. Komanduri K. V., Viswanathan M. N., Wieder E. D., Schmidt D. K., Bredt B. M., Jacobson M. A., McCune J. M. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat. Med. 4:1998;953-956.
20. Kuroda M., Schmitz J., Barouch D., Craiu A., Allen T., Sette A., Watkins D., Forman M., Letvin N. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1998;1373-1381.
21. Kuroda M., Schmitz J., Charini W., Nickerson C., Lord C., Forman M., Letvin N. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. J. Virol. 73:1999a;1573-1579.
22. Kuroda M. J., Schmitz J. E., Charini W. A., Nickerson C. E., Lifton M. A., Lord C. I., Forman M. A., Letvin N. L. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162:1999b;5127-5133.
23. Lalvani A., Brookes R., Hambleton S., Britton W. J., Hill A. V., McMichael A. J. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:1997;859-865.
24. Larsson M., Jin X., Ramratnam B., Ogg G. S., Engelmayer J., Demoitie M. A., McMichael A. J., Cox W. I., Steinman R. M., Nixon D., Bhardwaj N. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS. 13:1999;767-777.
25. Lee P. P., Yee C., Savage P. A., Fong L., Brockstedt D., Weber J. S., Johnson D., Swetter S., Thompson J., Greenberg P. D., Roederer M., Davis M. M. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:1999;677-685.
26. Lehner T., Wang Y., Cranage M., Bergmeier L. A., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Jones I., Doyle C. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Dev. Biol. Stand. 92:1998;225-235.
27. Letvin N. L. Progress in the development of an HIV-1 vaccine. Science. 280:1998;1875-1880.
28. Mascher B., Schlenke P., Seyfarth M. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J. Immunol. Methods. 223:1999;115-121.
29. Miller M. D., Yamamoto H., Hughes A. L., Watkins D. I., Letvin N. L. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol. 147:1991;320-329.
30. Murali-Krishna K., Altman J., Suresh M., Sourdive D., Zajac A., Miller J., Slansky J., Ahmed R. Counting antigen-specific CD8 T-cells: A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
31. Nilsson C., Makitalo B., Thorstensson R., Norley S., Binninger-Schinzel D., Cranage M., Rud E., Biberfeld G., Putkonen P. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS. 12:1998;2261-2270.
32. Ogg G. S., Jin X., Bonhoeffer S., Dunbar P. R., Nowak M. A., Monard S., Segal J. P., Cao Y., Rowland-Jones S. L., Cerundolo V., Hurley A., Markowitz M., Ho D. D., Nixon D. F., McMichael A. J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103-2106.
33. Ogg G. S., Jin X., Bonhoeffer S., Moss P., Nowak M. A., Monard S., Segal J. P., Cao Y., Rowland-Jones S. L., Hurley A., Markowitz M., Ho D. D., McMichael A. J., Nixon D. F. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:1999;797-800.
34. Pitcher C. J., Quittner C., Peterson D. M., Connors M., Koup R. A., Maino V. C., Picker L. J. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:1999;518-525.
35. Robinson H. L., Montefiori D. C., Johnson R. P., Manson K. H., Kalish M. L., Lifson J. D., Rizvi T. A., Lu S., Hu S. L., Mazzara G. P., Panicali D. L., Herndon J. G., Glickman R., Candido M. A., Lydy S. L., Wyand M. S., McClure H. M. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat. Med. 5:1999;526-534.
36. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women [published erratum appears in Nat. Med. 1, 598, 1995]. Nat Med. 1:1995;59-64.
37. Rowland-Jones S. L., Nixon D. F., Aldhous M. C., Gotch F., Ariyoshi K., Hallam N., Kroll J. S., Froebel K., McMichael A. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860-861.
38. Seth A., Ourmanov I., Kuroda M., Schmitz J., Carroll M., Wyatt L., Moss B., Forman M., Hirsch V., Letvin N. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer. Proc. Natl. Acad. Sci. USA. 95:1998;10112-10116.
39. Spiegel H. M., DeFalcon E., Ogg G. S., Larsson M., Beadle T. J., Tao P., McMichael A. J., Bhardwaj N., O'Callaghan C., Cox W. I., Krasinski K., Pollack H., Borkowsky W., Nixon D. F. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children. J. Infect. Dis. 180:1999;359-368.
40. Tan L. C., Gudgeon N., Annels N. E., Hansasuta P., O'Callaghan C. A., Rowland-Jones S., McMichael A. J., Rickinson A. B., Callan M. F. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1999;1827-1835.
41. Vogel T. U., Evans D. T., Urvater J. A., O'Connor D. H., Hughes A. L., Watkins D. I. Major histocompatibility complex class I genes in primates: Co-evolution with pathogens. Immunol. Rev. 167:1999;327-337.
42. Waldrop S., Pitcher C., Peterson D., Maino V., Picker L. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99:1997;1739-1750.
43. Zajac A. J., Blattman J. N., Murali-Krishna K., Sourdive D. J., Suresh M., Altman J. D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:1998;2205-2213.